Target discovery and validation is a key step in drug discovery, however, finding proper targets in related pathways can be challenging. Combining genomics/genome sequencing platform with sophisticated cell analysis, Creative Biolabs is able to quickly identify targets in virtually any biological matrix, nominally cell cultures, tissues or body fluids. Our target discovery services can help researchers who are practicing in the field such as breast cancer, melanoma, lung cancer, sarcomas, hematologic malignancies and others.
Creative Biolabs has developed an innovative phenotypic screening platform to update on the technology portfolio we currently serve. In the target-based screening, we are able to validate candidate target by combining a number of experimental methods, such as high-content screening, high-throughput gene expression analysis and human primary cell-based assays and some others. Using our AI-related systems, we can further validate the functions of disease targets and, hopefully, explain how the target modulations possess therapeutic effects.
Comprehensive services on DNA and RNA extraction, genotyping, sample preparation and NGS…
Gene expression profiling creates a global map of cellular function by measuring all gene activity…
CRISPR system is used to knock out or silence genes, suppress gene expression, or unregulated genes…
By using microscopic imaging to measure, and analyze multiple parametes within a cell in a bioassay …
CRISPR system is used to knock out or silence genes, suppress gene expression, or unregulated genes…
Our expertise on extensive analysis, reagents identification and library combination skills can surely facilitate the identification and validation of novel targets you are looking for.
Please feel free to contact us for more detailed information.
For Research Use Only | Not For Clinical Use